HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anargyros Xenocostas Selected Research

Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)

11/2014Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anargyros Xenocostas Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 08/2009
6Anemia
08/2017 - 01/2010
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 06/2011
4Hyperglycemia
01/2019 - 01/2012
4Hemorrhagic Shock
01/2017 - 06/2010
3Shock
01/2017 - 06/2010
3Myocardial Infarction
03/2012 - 01/2010
3Hypoxia (Hypoxemia)
10/2011 - 01/2007
3Ischemia
05/2009 - 02/2005
2Hemorrhage
01/2020 - 04/2008
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 04/2014
2Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 09/2019
2Pneumonia (Pneumonitis)
01/2017 - 01/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016 - 11/2014
2Lymphoma (Lymphomas)
11/2014 - 08/2009
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2014 - 03/2013
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2014 - 08/2013
2Leukemia
09/2014 - 06/2011
2Breast Neoplasms (Breast Cancer)
06/2012 - 10/2011
2Infarction (Infarctions)
03/2012 - 11/2010
2Sepsis (Septicemia)
11/2011 - 01/2007
1Edema (Dropsy)
01/2022
1Primary Myelofibrosis (Myelosclerosis)
12/2021
1Muscular Diseases (Myopathy)
03/2020
1Infections
01/2020
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020
1Hemochromatosis (Bronze Diabetes)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Atrial Fibrillation
01/2018
1Cardiac Arrhythmias (Arrythmia)
01/2018
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018
1Aplastic Anemia (Anemia, Hypoplastic)
01/2018
1Inflammation (Inflammations)
01/2017
1Acute Lung Injury
01/2017
1Reinjuries
01/2017
1Iron Deficiencies
01/2016
1Chronic Disease (Chronic Diseases)
01/2016
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
01/2016
1Chronic Renal Insufficiency
01/2016
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2016
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
11/2014
1Autoimmune Diseases (Autoimmune Disease)
04/2014
1Myasthenia Gravis
04/2014
1Multiple Organ Failure (MODS)
01/2014
1Posterior Leukoencephalopathy Syndrome
05/2012
1Multiple Myeloma
05/2012
1Neoplasm Metastasis (Metastasis)
10/2011
1Wounds and Injuries (Trauma)
11/2010

Drug/Important Bio-Agent (IBA)

11ErythropoietinFDA Link
05/2016 - 02/2005
6Hemoglobins (Hemoglobin)IBA
01/2020 - 01/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2012
3Proteins (Proteins, Gene)FDA Link
11/2018 - 07/2012
3HematinicsIBA
08/2017 - 10/2011
2Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2022 - 09/2019
2Dopamine Receptors (Dopamine Receptor)IBA
01/2021 - 06/2012
2Thioridazine (Mellaril)FDA LinkGeneric
01/2021 - 01/2018
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 07/2012
2HMGB1 Protein (HMG1)IBA
01/2017 - 01/2014
2salicylhydroxamic acid (SHAM)IBA
11/2011 - 01/2007
2NAD (NADH)IBA
06/2010 - 01/2007
1SodiumIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1A-Form DNA (A-DNA)IBA
09/2019
1Insulin (Novolin)FDA Link
01/2019
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2018
1ibrutinibIBA
01/2018
1C-PeptideIBA
01/2017
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2016
1Sunitinib (Sutent)FDA Link
11/2014
1CytokinesIBA
09/2014
1Tyrosine Kinase InhibitorsIBA
04/2014
1nilotinibFDA Link
04/2014
1Peroxidase (Myeloperoxidase)IBA
01/2014
1Rituximab (Mabthera)FDA Link
03/2013
1Messenger RNA (mRNA)IBA
07/2012
1Aldehyde DehydrogenaseIBA
07/2012
1Pharmaceutical PreparationsIBA
06/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1Thalidomide (Thalomid)FDA Link
05/2012
1SuspensionsIBA
11/2011
1Cytotoxins (Cytolysins)IBA
10/2011
1IronIBA
01/2010
1Phospholipase C betaIBA
08/2009

Therapy/Procedure

5Drug Therapy (Chemotherapy)
03/2020 - 10/2011
5Transplantation
01/2020 - 05/2009
4Therapeutics
01/2021 - 05/2009
4Resuscitation
01/2017 - 06/2010
3Blood Transfusion (Blood Transfusions)
03/2012 - 01/2010
3Ligation
03/2012 - 05/2009
2Liver Transplantation
12/2021 - 01/2018
2Stem Cell Transplantation
11/2014 - 03/2013
1Hematopoietic Stem Cell Transplantation
12/2021
1Length of Stay
01/2020
1Remission Induction
10/2018
1Splenectomy
01/2018
1Intravenous Injections
01/2012
1Heterologous Transplantation (Xenotransplantation)
06/2011